nomegestrol acetate has been researched along with Endometrial Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ma, AY; Xie, SW; Zhou, JY; Zhu, Y | 1 |
| Cao, C; Gong, YJ; Guo, XJ; Li, GT; Li, Z; Shao, HH; Xie, SW; Yang, WJ; Zhong, RH; Zhou, JY; Zhu, Y | 1 |
2 other study(ies) available for nomegestrol acetate and Endometrial Neoplasms
| Article | Year |
|---|---|
Nomegestrol Acetate Suppresses Human Endometrial Cancer RL95-2 Cells Proliferation In Vitro and In Vivo Possibly Related to Upregulating Expression of SUFU and Wnt7a.
Topics: Animals; Antineoplastic Agents, Hormonal; Cell Line, Tumor; Cell Proliferation; Endometrial Neoplasms; Endometrium; Female; Gene Expression Regulation, Neoplastic; Humans; Megestrol; Mice, Inbred BALB C; Mice, Nude; Norpregnadienes; Repressor Proteins; Up-Regulation; Wnt Proteins | 2017 |
Metformin Enhances Nomegestrol Acetate Suppressing Growth of Endometrial Cancer Cells and May Correlate to Downregulating mTOR Activity In Vitro and In Vivo.
Topics: Adaptor Proteins, Signal Transducing; Animals; Apoptosis; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Endometrial Neoplasms; Estrogen Receptor alpha; Eukaryotic Initiation Factor-4G; Female; Humans; Megestrol; Metformin; Mice, Nude; Norpregnadienes; Phosphorylation; Receptors, Progesterone; TOR Serine-Threonine Kinases; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2019 |